Ebi, LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$107Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
708clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System $64K associated (2023-2025)
- Spf Xl Iib Implantable Spinal Fusion Stimulator $33K associated (2023-2025)
- Biomet Orthopak Non-Invasive Bone Growth Stimulator System $27K associated (2023-2025)
- Ebi Osteogen Implantable Bone Growth Stimulator $25K associated (2023-2025)
- Biomet Ebi Bone Healing System $23K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| John Finkenberg | San Diego, CA | Orthopaedic Surgery | $15,177.50 |
| Cary Templin | Joliet, IL | Orthopaedic Surgery | $13,076.43 |
| Steven Bernstein | Fort Lee, NJ | Foot & Ankle Surgery | $9,171.52 |
| Brian Mullis | Indianapolis, IN | Orthopaedic Surgery | $8,172.53 |
| Tresa Wize | Beaver, PA | Foot & Ankle Surgery | $7,506.54 |
| Cyrus Wong | Fort Worth, TX | Neurological Surgery | $2,770.35 |
| Andrew Vivas | Valencia, CA | Neurological Surgery | $2,480.94 |
| Samuel Joseph | Safety Harbor, FL | Orthopaedic Surgery of The Spine | $1,888.21 |
| Sagar Chawla | Charlotte, NC | Foot and Ankle Surgery | $1,063.89 |
| Casey Davidson | Franklin, TN | Orthopaedic Surgery | $542.47 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.